SHPAX vs. FBTCX
Compare and contrast key facts about Saratoga Health & Biotechnology Fund (SHPAX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX).
SHPAX is managed by Saratoga. It was launched on Jul 14, 1999. FBTCX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
SHPAX vs. FBTCX - Performance Comparison
Loading graphics...
SHPAX vs. FBTCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | 0.66% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -5.30% | 11.78% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 2.09% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 24.82% | -4.55% | 24.81% |
Returns By Period
In the year-to-date period, SHPAX achieves a 0.66% return, which is significantly lower than FBTCX's 2.09% return. Over the past 10 years, SHPAX has underperformed FBTCX with an annualized return of 7.03%, while FBTCX has yielded a comparatively higher 10.32% annualized return.
SHPAX
- 1D
- 1.81%
- 1M
- -5.10%
- YTD
- 0.66%
- 6M
- 9.79%
- 1Y
- 15.26%
- 3Y*
- 7.57%
- 5Y*
- 5.93%
- 10Y*
- 7.03%
FBTCX
- 1D
- 5.09%
- 1M
- -0.81%
- YTD
- 2.09%
- 6M
- 15.10%
- 1Y
- 54.26%
- 3Y*
- 17.00%
- 5Y*
- 6.73%
- 10Y*
- 10.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SHPAX vs. FBTCX - Expense Ratio Comparison
SHPAX has a 2.90% expense ratio, which is higher than FBTCX's 1.75% expense ratio.
Return for Risk
SHPAX vs. FBTCX — Risk / Return Rank
SHPAX
FBTCX
SHPAX vs. FBTCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Saratoga Health & Biotechnology Fund (SHPAX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SHPAX | FBTCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.86 | 1.90 | -1.04 |
Sortino ratioReturn per unit of downside risk | 1.28 | 2.49 | -1.21 |
Omega ratioGain probability vs. loss probability | 1.16 | 1.32 | -0.16 |
Calmar ratioReturn relative to maximum drawdown | 1.89 | 3.08 | -1.20 |
Martin ratioReturn relative to average drawdown | 5.16 | 12.19 | -7.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SHPAX | FBTCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.86 | 1.90 | -1.04 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 0.29 | +0.13 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.43 | 0.42 | +0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.27 | +0.03 |
Correlation
The correlation between SHPAX and FBTCX is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
SHPAX vs. FBTCX - Dividend Comparison
SHPAX's dividend yield for the trailing twelve months is around 3.64%, more than FBTCX's 1.65% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | 3.64% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.65% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
Drawdowns
SHPAX vs. FBTCX - Drawdown Comparison
The maximum SHPAX drawdown since its inception was -69.50%, which is greater than FBTCX's maximum drawdown of -64.04%. Use the drawdown chart below to compare losses from any high point for SHPAX and FBTCX.
Loading graphics...
Drawdown Indicators
| SHPAX | FBTCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.50% | -64.04% | -5.46% |
Max Drawdown (1Y)Largest decline over 1 year | -7.87% | -13.63% | +5.76% |
Max Drawdown (5Y)Largest decline over 5 years | -16.32% | -37.26% | +20.94% |
Max Drawdown (10Y)Largest decline over 10 years | -28.05% | -39.37% | +11.32% |
Current DrawdownCurrent decline from peak | -5.31% | -2.75% | -2.56% |
Average DrawdownAverage peak-to-trough decline | -28.07% | -23.21% | -4.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.88% | 3.75% | -0.87% |
Volatility
SHPAX vs. FBTCX - Volatility Comparison
The current volatility for Saratoga Health & Biotechnology Fund (SHPAX) is 5.09%, while Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a volatility of 9.37%. This indicates that SHPAX experiences smaller price fluctuations and is considered to be less risky than FBTCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SHPAX | FBTCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.09% | 9.37% | -4.28% |
Volatility (6M)Calculated over the trailing 6-month period | 9.90% | 17.02% | -7.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.63% | 25.99% | -9.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.21% | 23.48% | -9.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.57% | 24.66% | -8.09% |